A Simple and Rapid Protocol to Non-enzymatically Dissociate Fresh Human Tissues for the Analysis of Infiltrating Lymphocytes

Podsumowanie

This protocol describes the rapid non-enzymatic dissociation of fresh human tissue fragments for qualitative and quantitative assessment of CD45⁺ cells (lymphocytes/leukocytes) present in various normal and malignant human tissues. Additionally, the supernatant obtained from the primary tissue homogenate can be collected and stored for further analysis or experimentation.

Streszczenie

The ability of malignant cells to evade the immune system, characterized by tumor escape from both innate and adaptive immune responses, is now accepted as an important hallmark of cancer. Our research on breast cancer focuses on the active role that tumor infiltrating lymphocytes play in tumor progression and patient outcome. Toward this goal, we developed a methodology for the rapid isolation of intact lymphoid cells from normal and abnormal tissues in an effort to evaluate them proximate to their native state. Homogenates prepared using a mechanical dissociator show both increased viability and cell recovery while preserving surface receptor expression compared to enzyme-digested tissues. Furthermore, enzymatic digestion of the remaining insoluble material did not recover additional CD45⁺ cells indicating that quantitative and qualitative measurements in the primary homogenate likely genuinely reflect infiltrating subpopulations in the tissue fragment. The lymphoid cells in these homogenates can be easily characterized using immunological (phenotype, proliferation, etc.) or molecular (DNA, RNA and/or protein) approaches. CD45⁺ cells can also be used for subpopulation purification, in vitro expansion or cryopreservation. An additional benefit of this approach is that the primary tissue supernatant from the homogenates can be used to characterize and compare cytokines, chemokines, immunoglobulins and antigens present in normal and malignant tissues. This protocol functions extremely well for human breast tissues and should be applicable to a wide variety of normal and abnormal tissues.

Wprowadzenie

The tumor microenvironment is composed of various cell types with numerous studies showing they each play distinct and important roles in tumorigenesis^1,2. These include, but are not limited to, infiltrating immune cells, stromal cells, endothelial cells and tumor cells³. Ex vivo studies of tumor infiltrating lymphocytes (TIL; CD45⁺ cells or leukocytes, which are predominantly lymphocytes in breast tumors) from fresh human tissue samples is made difficult by their low frequency, the small sample sizes often available for research and the potential for loss of viability during extraction. Because immune cells infiltrating tumors are usually present as passengers rather than permanent residents in general they are easier to release from the tissue matrix.

Dissociating tumor tissue while maintaining cellular integrity is technically challenging and has traditionally been performed using a combination of mechanical and enzymatic steps to prepare single cell suspensions^4-8. This approach involves lengthy incubation periods and is associated with a significant reduction in cell viability as well as the loss of cell surface receptors by enzymatic cleavage. High quality flow cytometric studies characterizing TIL in the tumor microenvironment as well as clean purifications of CD45⁺ subpopulations by flow cytometry or antibody-coated beads are more difficult to achieve from enzyme-digested tumor tissue. In addition, the supernatant (SN) from the resulting tumor homogenate is not amenable to further analysis including quantification of secreted proteins (cytokines, chemokines, immunoglobulins or tumor antigens) or experimental treatment of normal cells, because of the potential for protein degradation in the enzymatic digests.

In our search for a method to prepare single cell homogenates from breast tissues [including tumor, non-adjacent non-tumor (NANT) and normal (from mammary reductions) breast tissues] without enzymatic digestion, we tested a variety of mechanical homogenization techniques. Homogenates prepared using a mechanical dissociator had increased cell viability (2-fold) and total cell recovery (2-fold) while preserving surface receptor expression. Enzymatic digestion of the remaining insoluble material did not recover additional CD45⁺ cells suggesting they were all released in the initial homogenate. Thus, this rapid and simple approach allows both qualitative and quantitative assessment of the CD45⁺ subpopulations present in various normal and malignant human tissues. An added advantage of this approach is that the SN from the initial homogenate (primary tissue SN) can be collected and stored for further analysis or experimentation.

Protokół

NOTE: All specimens were acquired using a protocol approved by the Medical Ethics Committee of the Institute Jules Bordet with written informed consent obtained from each patient.

1. Preparation of the Tissue Homogenate

1. Dissect resected tissues (malignant and normal tissue resected from the operating room) are in the pathology lab by trained personnel for immediate pickup. Tumor, NANT (taken the furthest distance from the tumor as possible) and normal tissue fragments are routinely processed within 1 - 3 hr of surgical excision in a BSL2 laboratory using standard biosafety procedures for human tissues. A flow chart of the protocol is illustrated in Figure 1.
2. Weigh all tissue fragments (normal, NANT and tumor) and measure the length, width, and height (length x width x height). This is an important step for the subsequent normalization of cell subpopulations, extracted RNA, etc.
   NOTE: The range of sample size is 100 to 10,000 mm³ with no fat if possible.
3. Imprint the tumor fragment on a glass slide for H&E staining to verify that the tissue is actually part of the tumor.
   1. Do this by pressing a glass microscope slide on the tumor fragment and applying gentle pressure with your fingers for a few seconds.
   2. Fix the slide with isopropanol for 2 min followed by a washing step in water. Counterstain the tissue for 30 sec with Mayer's hematoxylin.
   3. Wash the slide in six baths of water. Stain in Phloxine B 2% for 15 sec.
   4. Wash in one bath of water followed by four baths of isopropanol and finish with one bath of water.
   5. Incubate in isopropanol for 1 min and drain. Clear in two baths of xylene.
   6. Mount with xylene based mounting medium. Examine for tumor cellularity (Figure 2).
      NOTE: Mainly, tumor cells stick to the imprinted slide - the stromal, lymphoid or adipose cells rarely remain, leaving spaces between the tumor cells (Figure 2).
4. Place the tissue fragment in a small culture dish containing 1 ml of the chemically defined, serum-free hematopoietic cell medium (hereafter referred to as medium) at room temperature and dice it into small pieces (~1 - 2 mm²) using a sterile scalpel.
5. Transfer everything (tissue fragments + medium) to a mechanical dissociator C tube.
6. Rinse the Petri dish and scalpel with 2 ml of medium using a Pasteur pipette and add this to the C tube (volume of medium for dissociation = 3 ml).
7. Use the mechanical dissociator program A.01 for C tubes (the most gentle program) to homogenize the tissue fragments into a single cell suspension. Place the C tube in the apparatus and run the program twice in succession (one cycle = 25 sec).
   NOTE: This homogenization procedure has been established and validated for human breast tissue, other tumor or tissue types may need to use a different program and should be tested first.
8. Remove the C tube from the apparatus and decant the homogenate directly into a 40 μm cell strainer seated on a 50 ml tube. Using the same Pasteur pipette as in step 1.6, transfer any liquid remaining in the C tube to the cell strainer.
9. Transfer the filtered liquid into a 15 ml tube using a 1 ml micropipette tip. Temporarily keep the cell strainer and its 50 ml tube.
10. Rinse the C tube with an additional 3 ml of medium and transfer this, again using the same Pasteur pipette as in step 1.6, to the cell strainer still seated on the 50 ml tube. Squeeze a maximum amount of the residual liquid trapped in the unhomogenized tissue into the 50 ml tube by gently moving it around the strainer with a clean Pasteur pipette or 1 ml tip that is subsequently thrown away to avoid contaminating the eluate.
11. Place the cell strainer upside down on the original C tube and rinse with 3 ml of medium so that the unhomogenized tissue drops back into the C tube.
12. Re-homogenize as in step 1.7 for two cycles of the A.01 program.
13. Pour this second homogenate through the cell strainer seated on the 50 ml tube, rinse the C tube again with 3 ml medium (as in step 1.10) and transfer with the Pasteur pipette to the cell strainer seated on the 50 ml tube again squeezing a maximum amount of liquid from the residual connective tissue trapped in the cell strainer.
14. At this point, a volume of ~2.5 ml is in the 15 ml tube and ~9 ml in the 50 ml tube.

2. Separation of the Tissue Supernatant and Cells

1. Centrifuge the homogenates in the 15 ml and 50 ml tubes for 15 min at 600 x g at room temperature.
2. Decant the SN from the 15 ml tube into a clean tube and temporarily store at 4 °C. This supernatant = primary tumor, NANT or normal tissue SN (final volume 2.5 ml) is subsequently clarified and aliquoted prior to storage at -80 °C for future analyses (see below).
3. Discard the supernatant from the 50 ml tube.
4. Gently resuspend both cell pellets in a final volume of 1 ml medium. Briefly, first gently break the cell pellet in both tubes (by tapping the tube on a hard surface). Resuspend the loose cell pellet in the 50 ml with 500 µl of medium and transfer this cell suspension to the 15 ml tube to resuspend the second pellet. Repeat this step once with the second 500 µl of medium for maximum recovery of cells.
5. Transfer 10 µl of the cell suspension to a small tube, mix with 10 µl of trypan blue (dilution 1:1) and count the number of viable cells using a hemocytometer.
   NOTE: At this point a fraction of the cell suspension can also be analyzed by flow cytometry to evaluate cell size, granularity and if desired a limited number of subpopulation markers for more precise assessment of the relative cell distribution in the homogenate prior to extensive analysis or experimentation. All analyses by flow cytometry incorporate CD45 labeling for normalization of subpopulations.
6. Pellet the cells by centrifugation at 300 x g for 10 min at room temperature. The cells from the tumor, NANT, or normal tissue are now ready for further purification or analysis. These additional steps are best when performed on the same day as surgery.
   NOTE: For flow cytometric analysis but not cell sorting the residual red blood cells should be lysed after antibody labeling by adding 0.4 ml of red blood cell lysis buffer to the cell pellet, immediately vortexing for 1 sec and incubating a minimum of 10 min at room temperature (protected from light) before analysis.

3. Clarification of the Tissue Supernatant

1. Centrifuge the 1.5 ml tubes with tissue SN at 15,000 x g for 15 min at 4 °C.
2. Carefully remove the supernatant without touching or disturbing the pellet. Transfer to a clean tube (or tubes) depending upon the number and volume of aliquots desired.
3. Store the supernatant at -80 °C for future use.

4. Patient Blood

1. Collect a blood sample from each patient as a control by venipuncture into heparinized tubes the day prior to surgery. Centrifuge the blood at 400 x g for 10 min at 20 ºC with the brake off to obtain the plasma and a buffy coat.
2. Remove the plasma and clarify it by centrifugation at 10,000 x g for 15 min at 20 ºC. Aliquot and store plasma at -80 °C for future use. Dilute the buffy coat in medium
3. Separate the mononuclear cells using standard ficoll-hypaque gradient centrifugation prior to immediate analysis, subpopulation isolation, DNA/RNA/protein extraction or cryopreservation.

5. Flow Cytometry

1. Label cells according to manufacturer’s instructions at 4 °C, protected from light. Lyse red blood cells in cell suspensions from tissue fragments after antibody labeling by adding 0.4 ml of cell lysis buffer to the cell pellet.
2. Vortex immediately for 1 sec and incubate a minimum of 10 min at room temperature, protected from light. Pass the labeled cells in a flow cytometer for data acquisition without washing.

Wyniki

Enzymatic digestion of tissue fragments with either commercially available tissue dissociation solutions or various laboratory mixtures of collagenase, DNase and/or hyaluronidase inhibitors, cleave a wide variety of receptors on the surface of cells. Our studies, initially focused on CD4⁺ T cells infiltrating breast tumors, were quickly presented with a major technical problem due to cleavage of surface CD4 receptors using standard enzymatic digestion protocols^4-8. We tested a variety of collagenase...

Dyskusje

This study describes an optimized method for the rapid preparation of normal and malignant breast tissue homogenates without enzymatic digestion for subsequent cell sorting, extraction, cryopreservation and/or phenotypic analysis of CD45⁺ subpopulations. The goal of this experimental approach is to produce images of the TIL that closely reflect their in vivo state and compare them to normal tissues with minimal manipulation of the tissues fresh from the operating room. To date, our laboratory has used...

Materiały

Name	Company	Catalog Number	Comments
GentleMacs Dissociator	Miltenyi Biotec	130-093-235	BD Medimachine is somewhat equivalent
Centrifuge 5810 R	Eppendorf		or other standard table top centrifuge
Centrifuge 5417 R	Eppendorf		or other standard microcentrifuge
Esco Class II A2 Biosafety Cabinet	ESCO global		or other standard BSL2 hood
Inverted Microscope	Nikon eclipse TS100		or other microscope compatible for a hemacytometer
Bürker Chamber	Marienfield	640210	or other standard hemacytometer
Navios Flow Cytometer	Beckman Coulter		or other flow cytometer (8-10 color recommended)
GentleMacs C-Tube	Miltenyi Biotec	130-096-344	BD Medimachine uses Filcon
Cell Culture Dish	Sarstedt	72,710	or other non-pyrogenic plasticware
Disposable Scalpel	Swann-Morton	0510	or standard single use sterile scalpel
BD Cell Strainer 40 µm	Becton Dickinson	734-0002	or other non-pyrogenic plasticware
BD Falcon Tube 50 ml	Becton Dickinson	352070	or other non-pyrogenic plasticware
BD Falcon Tube 15 ml	Becton Dickinson	352097	or other non-pyrogenic plasticware
BD FACS Tube 5 ml	Becton Dickinson	352008	or other non-pyrogenic plasticware
Sterile Pasteur Pipette 5 ml	VWR	612-1685	or other non-pyrogenic plasticware
Microfuge Tube 1.5 ml	Eppendorf	7805-00	or other non-pyrogenic plasticware
X-Vivo 20	Lonza	BE04-448Q	serum-free medium recommended
Phosphate buffered saline	Lonza	BE17-516F	standard physiological PBS
Trypan blue	VWR	17942E	or other vital stain
VersaLyse	Beckman Coulter	A09777	for flow cytometry experiments
Fixable viability Dye eFluor 780	eBioscience	65-0865-14	for flow cytometry experiments
anti-CD3 FITC	BD Biosciences	345763	for flow cytometry experiments
anti-CD3 Vio Blue	Miltenyi Biotec	130-094-363	for flow cytometry experiments
anti-CD4 PE	BD Biosciences	345769	for flow cytometry experiments
anti-CD4 APC	Miltenyi Biotec	130-091-232	for flow cytometry experiments
anti-CD8 ECD	Beckman Coulter	737659	for flow cytometry experiments
anti-CD8 PerCP	BD Biosciences	345774	for flow cytometry experiments
anti-CD19 APC-Vio770	Miltenyi Biotec	130-096-643	for flow cytometry experiments
anti-CD45 VioGreen	Miltenyi Biotec	130-096-906	for flow cytometry experiments